Discussing uproleselan potential in relapsed/refractory AML and the ongoing phase 3 study

Executed on:Feb 15, 2024 11:30 AM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: Yale​Assistant Professor of Medicine (Hematology) at Yale.
Focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Participated in the K12 Calabresi Immuno-Oncology Training Program and has participated in several clinical trials aimed at improving the outcomes of patients with AML and MDS.

Interview Goal

Discuss current treatment algorithm in AML and outlook for uproleselan

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.